Nonbronchial systemic collateral arteries

Significance in percutaneous embolotherapy for hemoptysis

Frederick Keller, Josef Rosch, T. G. Loflin, P. H. Nath, R. B. McElvein

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Twenty patients with massive or recurrent hemoptysis underwent percutaneous transcatheter embolotherapy between 1979 and 1986 for the following diseases: cavitary aspergillosis (n = 4); cystic fibrosis (n = 4); tuberculosis (n = 3);bronchogenic carcinoma (n = 3); bronchiectasis (n = 3); small cell lung carcinoma 6 years after irradiation (n = 1); congenital heart disease, after Glenn and Blalock anastomoses (n = 1); and unknown interstitial disease (n = 1). Bronchial arteries were embolized in all but one patient. In nine patients (45%) nonbronchial systemic collateral arteries contributed significantly to areas of pathologic pulmonary tissue and frequently were the major arterial supply. These nonbronchial systemic collaterals included branches of the subclavian and axillary arteries (n = 7), intercostal arteries (n = 5), and phrenic arteries (n = 3) and accounted for 59.5% of the total number of arteries embolized. Recognition and occlusion of nonbronchial systemic collaterals providing blood to hypervascular pulmonary lesions is essential for successful percutaneous embolotherapy of hemoptysis.

Original languageEnglish (US)
Pages (from-to)687-692
Number of pages6
JournalRadiology
Volume164
Issue number3
StatePublished - 1987
Externally publishedYes

Fingerprint

Therapeutic Embolization
Hemoptysis
Arteries
Axillary Artery
Bronchial Arteries
Lung
Subclavian Artery
Bronchiectasis
Aspergillosis
Bronchogenic Carcinoma
Small Cell Lung Carcinoma
Diaphragm
Cystic Fibrosis
Heart Diseases
Tuberculosis

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Keller, F., Rosch, J., Loflin, T. G., Nath, P. H., & McElvein, R. B. (1987). Nonbronchial systemic collateral arteries: Significance in percutaneous embolotherapy for hemoptysis. Radiology, 164(3), 687-692.

Nonbronchial systemic collateral arteries : Significance in percutaneous embolotherapy for hemoptysis. / Keller, Frederick; Rosch, Josef; Loflin, T. G.; Nath, P. H.; McElvein, R. B.

In: Radiology, Vol. 164, No. 3, 1987, p. 687-692.

Research output: Contribution to journalArticle

Keller, F, Rosch, J, Loflin, TG, Nath, PH & McElvein, RB 1987, 'Nonbronchial systemic collateral arteries: Significance in percutaneous embolotherapy for hemoptysis', Radiology, vol. 164, no. 3, pp. 687-692.
Keller, Frederick ; Rosch, Josef ; Loflin, T. G. ; Nath, P. H. ; McElvein, R. B. / Nonbronchial systemic collateral arteries : Significance in percutaneous embolotherapy for hemoptysis. In: Radiology. 1987 ; Vol. 164, No. 3. pp. 687-692.
@article{d6717d627f3549f4a38048165f088cd0,
title = "Nonbronchial systemic collateral arteries: Significance in percutaneous embolotherapy for hemoptysis",
abstract = "Twenty patients with massive or recurrent hemoptysis underwent percutaneous transcatheter embolotherapy between 1979 and 1986 for the following diseases: cavitary aspergillosis (n = 4); cystic fibrosis (n = 4); tuberculosis (n = 3);bronchogenic carcinoma (n = 3); bronchiectasis (n = 3); small cell lung carcinoma 6 years after irradiation (n = 1); congenital heart disease, after Glenn and Blalock anastomoses (n = 1); and unknown interstitial disease (n = 1). Bronchial arteries were embolized in all but one patient. In nine patients (45{\%}) nonbronchial systemic collateral arteries contributed significantly to areas of pathologic pulmonary tissue and frequently were the major arterial supply. These nonbronchial systemic collaterals included branches of the subclavian and axillary arteries (n = 7), intercostal arteries (n = 5), and phrenic arteries (n = 3) and accounted for 59.5{\%} of the total number of arteries embolized. Recognition and occlusion of nonbronchial systemic collaterals providing blood to hypervascular pulmonary lesions is essential for successful percutaneous embolotherapy of hemoptysis.",
author = "Frederick Keller and Josef Rosch and Loflin, {T. G.} and Nath, {P. H.} and McElvein, {R. B.}",
year = "1987",
language = "English (US)",
volume = "164",
pages = "687--692",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "3",

}

TY - JOUR

T1 - Nonbronchial systemic collateral arteries

T2 - Significance in percutaneous embolotherapy for hemoptysis

AU - Keller, Frederick

AU - Rosch, Josef

AU - Loflin, T. G.

AU - Nath, P. H.

AU - McElvein, R. B.

PY - 1987

Y1 - 1987

N2 - Twenty patients with massive or recurrent hemoptysis underwent percutaneous transcatheter embolotherapy between 1979 and 1986 for the following diseases: cavitary aspergillosis (n = 4); cystic fibrosis (n = 4); tuberculosis (n = 3);bronchogenic carcinoma (n = 3); bronchiectasis (n = 3); small cell lung carcinoma 6 years after irradiation (n = 1); congenital heart disease, after Glenn and Blalock anastomoses (n = 1); and unknown interstitial disease (n = 1). Bronchial arteries were embolized in all but one patient. In nine patients (45%) nonbronchial systemic collateral arteries contributed significantly to areas of pathologic pulmonary tissue and frequently were the major arterial supply. These nonbronchial systemic collaterals included branches of the subclavian and axillary arteries (n = 7), intercostal arteries (n = 5), and phrenic arteries (n = 3) and accounted for 59.5% of the total number of arteries embolized. Recognition and occlusion of nonbronchial systemic collaterals providing blood to hypervascular pulmonary lesions is essential for successful percutaneous embolotherapy of hemoptysis.

AB - Twenty patients with massive or recurrent hemoptysis underwent percutaneous transcatheter embolotherapy between 1979 and 1986 for the following diseases: cavitary aspergillosis (n = 4); cystic fibrosis (n = 4); tuberculosis (n = 3);bronchogenic carcinoma (n = 3); bronchiectasis (n = 3); small cell lung carcinoma 6 years after irradiation (n = 1); congenital heart disease, after Glenn and Blalock anastomoses (n = 1); and unknown interstitial disease (n = 1). Bronchial arteries were embolized in all but one patient. In nine patients (45%) nonbronchial systemic collateral arteries contributed significantly to areas of pathologic pulmonary tissue and frequently were the major arterial supply. These nonbronchial systemic collaterals included branches of the subclavian and axillary arteries (n = 7), intercostal arteries (n = 5), and phrenic arteries (n = 3) and accounted for 59.5% of the total number of arteries embolized. Recognition and occlusion of nonbronchial systemic collaterals providing blood to hypervascular pulmonary lesions is essential for successful percutaneous embolotherapy of hemoptysis.

UR - http://www.scopus.com/inward/record.url?scp=0023232513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023232513&partnerID=8YFLogxK

M3 - Article

VL - 164

SP - 687

EP - 692

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 3

ER -